https://www.selleckchem.com/pr....oducts/pargyline-hyd
1. Only a higher number of cycles given was positively associated with PR (P=.005). All patients underwent complete resection, regardless of the tumor response. Overall, patients whose tumors demonstrated PD before surgery showed markedly worse OS (P=.005). An indication of a better clinical outcome was seen in specific regimens given for grade 3 dedifferentiated liposarcoma and leiomyosarcoma. In patients with high-risk RPS, the response to neoadjuvant systemic therapy is fair overall. Disease progression on therapy may
Aimer
Commentaire
Partagez
